EBSCO Knowledge Advantage TM

Acute lymphocytic leukemia (ALL)

Acute lymphocytic leukemia (ALL) is a fast-growing cancer of the white blood cells, specifically affecting lymphocytes, which are crucial for fighting infections. This condition occurs when the bone marrow produces abnormal lymphocytes that crowd out normal blood cells, leading to various symptoms such as anemia, frequent infections, and bone pain. While the exact causes are not fully understood, certain risk factors have been identified, including high doses of radiation, exposure to benzene, and genetic disorders. ALL is most common in children under five and is the predominant type of leukemia in this age group, accounting for 75 to 80% of pediatric leukemia cases.

Diagnosis typically involves blood and bone marrow tests, which help determine the specific type of ALL and guide treatment decisions. Treatment usually begins immediately and may include induction therapy to reach remission, followed by post-induction therapy to eliminate remaining cancer cells. The prognosis for children with ALL is generally favorable, with approximately a 90% five-year survival rate, while adults also see improvements in treatment outcomes. Ongoing advancements in gene therapy and other treatments continue to enhance the potential for successful management of ALL.

Published in: 2024
By: Madsen, Marianne M., M.S.
Go to EBSCOhost and sign in to access more content about this topic.

Acute lymphocytic leukemia (ALL)

ALSO KNOWN AS: Acute childhood leukemia, acute lymphoblastic leukemia, acute lymphoid leukemia

RELATED CONDITIONS: Acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia

DEFINITION: Acute lymphocytic leukemia (ALL) is a cancer of the white blood cells. A lymphocyte is a type of white blood cell made in the bone marrow that helps fight infection. In this fast-growing type of cancer, for unknown reasons, the bone marrow begins to make lymphocytes that develop abnormally. “Acute” means that the disease affects lymphocytes before they are fully formed and that it progresses rapidly if not treated.

Risk factors: Few risk factors exist for ALL. Receiving high doses of radiation, usually as treatment for another type of cancer, is one risk factor. Exposure to benzene may also be a factor. Risk increases in people with certain other diseases, such as Down syndrome, Fanconi anemia, Bloom syndrome, and some other genetic diseases. In about